Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C27H31N2O6S2.Na |
| Molecular Weight | 566.665 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].CCN(CC)C1=CC=C(C=C1)C(=C2C=CC(C=C2)=[N+](CC)CC)C3=C(C=CC(=C3)S([O-])(=O)=O)S([O-])(=O)=O
InChI
InChIKey=NLUFDZBOHMOBOE-UHFFFAOYSA-M
InChI=1S/C27H32N2O6S2.Na/c1-5-28(6-2)22-13-9-20(10-14-22)27(21-11-15-23(16-12-21)29(7-3)8-4)25-19-24(36(30,31)32)17-18-26(25)37(33,34)35;/h9-19H,5-8H2,1-4H3,(H-,30,31,32,33,34,35);/q;+1/p-1
| Molecular Formula | C27H31N2O6S2 |
| Molecular Weight | 543.675 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Na |
| Molecular Weight | 22.98976928 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Isosulfan Blue is a synthetic visual lymphatic imaging agent. Injected into the periphery of the tumor site, isosulfan blue localizes to the lymphatic system and aids in the surgical identification of tumor sentinel nodes which stain blue. The chemical name of isosulfan blue is N-[4-[[4-(diethylamino)phenyl] (2,5-disulfophenyl) methylene]-2,5-cyclohexadien-1-ylidene]-N-ethylethanaminium hydroxide, inner salt, sodium salt. Isosulfan blue is a greenish blue color hygroscopic powder. Isosulfan blue injection 1% is a contrast agent for the delineation of lymphatic vessels. Isosulfan blue injection 1% upon subcutaneous administration, delineates lymphatic vessels draining the region of injection. It is an adjunct to lymphography in: primary and secondary lymphedema of the extremities; chyluria, chylous ascites or chylothorax; lymph node involvement by primary or secondary neoplasm; and lymph node response to therapeutic modalities.
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
3 mL single, subcutaneous Studied dose Dose: 3 mL Route: subcutaneous Route: single Dose: 3 mL Sources: |
unhealthy Health Status: unhealthy Sources: |
Other AEs: Hypersensitivity, Respiratory distress... Other AEs: Hypersensitivity (2%) Sources: Respiratory distress (grade 4) Shock (grade 4) Angioedema (grade 4) Urticaria (grade 4) Pruritus (grade 4) |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Hypersensitivity | 2% | 3 mL single, subcutaneous Studied dose Dose: 3 mL Route: subcutaneous Route: single Dose: 3 mL Sources: |
unhealthy Health Status: unhealthy Sources: |
| Angioedema | grade 4 | 3 mL single, subcutaneous Studied dose Dose: 3 mL Route: subcutaneous Route: single Dose: 3 mL Sources: |
unhealthy Health Status: unhealthy Sources: |
| Pruritus | grade 4 | 3 mL single, subcutaneous Studied dose Dose: 3 mL Route: subcutaneous Route: single Dose: 3 mL Sources: |
unhealthy Health Status: unhealthy Sources: |
| Respiratory distress | grade 4 | 3 mL single, subcutaneous Studied dose Dose: 3 mL Route: subcutaneous Route: single Dose: 3 mL Sources: |
unhealthy Health Status: unhealthy Sources: |
| Shock | grade 4 | 3 mL single, subcutaneous Studied dose Dose: 3 mL Route: subcutaneous Route: single Dose: 3 mL Sources: |
unhealthy Health Status: unhealthy Sources: |
| Urticaria | grade 4 | 3 mL single, subcutaneous Studied dose Dose: 3 mL Route: subcutaneous Route: single Dose: 3 mL Sources: |
unhealthy Health Status: unhealthy Sources: |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:27:38 GMT 2025
by
admin
on
Mon Mar 31 18:27:38 GMT 2025
|
| Record UNII |
39N9K8S2A4
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C461
Created by
admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
50108
Created by
admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
|
PRIMARY | |||
|
SUB182640
Created by
admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
|
PRIMARY | |||
|
27863
Created by
admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
|
PRIMARY | RxNorm | ||
|
39N9K8S2A4
Created by
admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
|
PRIMARY | |||
|
C025484
Created by
admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
|
PRIMARY | |||
|
CHEMBL1615783
Created by
admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
|
PRIMARY | |||
|
8071
Created by
admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
|
PRIMARY | |||
|
734902
Created by
admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
|
PRIMARY | |||
|
39N9K8S2A4
Created by
admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
|
PRIMARY | |||
|
DTXSID8057805
Created by
admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
|
PRIMARY | |||
|
68238-36-8
Created by
admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
|
PRIMARY | |||
|
100000168999
Created by
admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
|
PRIMARY | |||
|
4503
Created by
admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
|
PRIMARY | |||
|
DB09136
Created by
admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
|
PRIMARY | |||
|
C1386
Created by
admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
|
PRIMARY | |||
|
m10387
Created by
admin on Mon Mar 31 18:27:38 GMT 2025 , Edited by admin on Mon Mar 31 18:27:38 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |